Korean J Clin Neurophysiol.
2016 Jun;18(1):14-17. 10.14253/kjcn.2016.18.1.14.
Pulmonary Thromboembolism after Intravenous Immunoglobulin Therapy in Guillain-Barre Syndrome
- Affiliations
-
- 1Department of Neurology, Dongguk University, School of Medicine, Gyeongju, Korea.
- 2Divison of Cardiology, Department of Internal Medicine, Kyungpook National University, School of Medicine, Daegu, Korea.
- 3Department of Neurology, Kyungpook National University, School of Medicine, Daegu, Korea. jinforeva@gmail.com
- KMID: 2328823
- DOI: http://doi.org/10.14253/kjcn.2016.18.1.14
Abstract
- Intravenous immunoglobulin (IVIG) is a safe treatment to treat various neurological disorders, but fatal thrombotic events as rare complications have been reported. A 54-year-old woman with Guillain-Barre syndrome complained of dyspnea during IVIG treatment. She was finally diagnosed with pulmonary thromboembolism. To the best of our knowledge, this is the first case of pulmonary thromboembolism associated with IVIG treatment in a Korean patient with Guillain-Barre syndrome.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Rapid Improvement of Symptoms in Severe Guillain-Barre Syndrome after Additional Use of Intravenous Immunoglobulin
- A Case of Cerebral Infarction Following Intravenous Immunoglobulin Therapy in a Patient with Guillain-Barre Syndrome
- A Case of Pompholyx Following Intravenous Immunoglobulin Therapy in Guillain-Barre Syndrome
- Pseudohyponatremia After Intravenous Immunoglobulin Therapy in a Patient With Guillain-Barre Syndrome
- SIADH and Guillain-Barre Syndrome Associated with Pulmonary Tuberculosis
